High dose rate endobronchial brachytherapy effectively palliates symptoms due to inoperable lung cancer.

Creative Commons License

Celebioglu B. , Gurkan O., Erdogan S., Savas I., Kose K., Kurtman C., ...Daha Fazla

Japanese journal of clinical oncology, cilt.32, ss.443-8, 2002 (SCI Expanded İndekslerine Giren Dergi) identifier identifier identifier

  • Cilt numarası: 32 Konu: 11
  • Basım Tarihi: 2002
  • Doi Numarası: 10.1093/jjco/hyf102
  • Dergi Adı: Japanese journal of clinical oncology
  • Sayfa Sayıları: ss.443-8


Background: Intraluminal brachytherapy has become an established treatment for major airway occlusion by relapsed or persistent inoperable endobronchial tumors. The aim of this study was to compare the palliation improvement pre- and post-radiotherapy.